Serial crystallography (SX) allows crystal structures to be observed at room temperature through the steady delivery of crystals to the X-ray interaction point. Viscous delivery media are advantageous because they afford efficient sample delivery from an injector or syringe at a low flow rate. Hydrophobic delivery media, such as lipidic cubic phase (LCP) or grease, provide a very stable injection stream and are widely used. The development of new hydrophobic delivery materials can expand opportunities for future SX studies with various samples. Here, I introduce fat-based shortening as a delivery medium for SX experiments.
Introduction
Serial crystallography (SX) using an X-ray free electron laser (XFEL) or synchrotron X-ray sources allows crystal structure to be determined without radiation damage or low dose data collection, respectively. [1] [2] [3] [4] This technique not only determines the room temperature structure, but also enables the time-resolved molecular dynamics to be visualized through pump-probe experiments. 1-4 Therefore, SX experiments allow for in-depth analyses of the being much less expensive than previously reported sample delivery media. In general, shortening has a solid state at room temperature and can be changed to a liquid state by raising its temperature, which is considered useful for sample preparation.
Here, I introduce the characterization and preparation of a shortening injection matrix for serial crystallography. The background scattering in shortening was negligible in data processing and showed similar or low scattering intensity compared to that of LCP. SMX experiments were performed using commercially available shortening, and the room temperature crystal structures of lysozyme and glucose isomerase were determined at resolutions of 1.5-2.0 Å. Shortening can be used for crystal delivery for SFX or SMX experiments.
Results and Discussion

Characterization and preparation of shortening injection matrix
In this experiment, two types of commercially available oil-based shortening were used, which are denoted as shortening A (composed of palm oil and tallow) and shortening B (composed of palm oils, tallow, and tocopherol). Commercially available shortening can exhibit physically varying melting points, 28 which is due to the composition of the shortening, the proportions of oils, and the manufacturing process. 27 To apply shortening to an injection matrix for an SX experiment, the melting temperatures of shortenings A and B were screened in the range of 20 to 40 °C. The results showed that the melting temperatures of shortenings A and B were approximately 28.5 and 26.5 °C, respectively.
Next, the sample preparation method using shortening was established for the SX experiment. The crystals embedded in shortenings A and B were prepared by mechanical mixing using a dual syringe setup ( Figure 1 ). Because the melting temperature of the shortening is below typical body temperature, the liquid phase of the shortening can be achieved by holding the glass vial containing the shortening by hand, but this takes several minutes. To reduce sample preparation time, in this experiment, the glass vial containing the shortening was immersed in hot water (~100 °C) in a beaker for approximately 10-20 s to obtain its liquid phase ( Figure 1a ). The liquid phase shortening was transferred to a 100 μ l syringe using the pipette and kept at room temperature or low temperature in an incubator until solidified ( Figure 1a ). The crystal suspension was transferred to another syringe using a pipette ( Figure 1b ). This syringe was then placed vertically and left for at least 10 minutes (see below). When the crystals sank to the bottom, the plunger was pushed upwards and the supernatant of the crystal suspension was removed, leaving the crystals (Figure 1b ). Next, two syringes containing shortening and crystals were connected using a coupler and the sample was gently mixed by moving the plunger back and forth until the crystal sample was evenly distributed (Figure 1c ). The mixture sample of crystals and shortening was transferred to a syringe, and the partner syringe with the coupler was removed. After connecting the syringe needle to syringe containing the mixture, the crystals embedded in the shortening were extruded from the syringe needle using a syringe pump (Figure 1d ).
Screening the injection stream of shortening
To determine whether shortening can deliver the crystal sample for SX, stable injection streams for shortenings A and B were investigated using a commercially available syringe The main component of shortening is the hydrophobic lipid triglyceride, whereas the crystal solution is hydrophilic. Therefore, the shortening and crystal suspension have different polarities. To achieve a stable shortening injection stream, a suitable ratio of shortening to crystal suspension was investigated. In the mechanical mixing method using a dual syringe setup, the shortening was mixed with lysozyme crystal suspension at ratios of 5:5, 6:4, 7:3, 8:2, and 9:1. When the crystal solution was more than 30%, an unmixed crystal solution was ejected in the middle of the shortening injection stream and disrupted the continuous injection stream. By contrast, less than 20% of the crystal solution provided a stable shortening injection stream. However, chemically minimizing the crystal solution produced a more continuous injection stream. Therefore, a syringe containing a crystal sample was set up vertically before the dual mixing, and when the crystals had settled, the upper layer crystal solution was removed and then mixed with the shortening (Figure 1c ). The percentage of settled crystal suspension was approximately 15-20% of the total, and the shortening containing crystals provided a steady and stable injection stream like LCP injection.
Measurement of background scattering
The X-ray exposed sample delivery media generate background scattering, which can affect the signal-to-noise (SNR) ratio during data processing. 19, 21 The background scattering from the delivery medium is one of the most important criteria for delivery medium selection for SX experiments. 22 The analyses of the background scattering of shortenings A and B were performed with the LCP delivery medium consisting of 60% (v/v) monoolein. The delivery media were extruded from the syringe needle with a 168 μ m ID, and they were exposed to X-ray radiation with a photon flux of 1.3 x 10 12 for 100 ms. For shortening A, five background scattering rings were observed at 3. 90, 4.26, 4.41,14.32, and 44 .02 Å (Figure 3a Figure   3c ). Analysis of the 2D profile of background scattering intensity revealed that shortening A had slightly higher background scattering intensity than LCP at approximately 45 Å and 3.0-5.5 Å (Figure 3c ). On the other hand, shortening B showed lower overall intensities of background scattering than LCP, excluding the intensity of the scattering ring at approximately 14 Å (Figure 3c ). Therefore shortening can have different background scattering depending on its production process and composition, and the shortening used in this study showed similar or slightly lower background scattering compared to LCP.
SMX using the shortening injection matrix
To demonstrate the application of a shortening injection matrix, SMX experiments using shortenings A and B were performed with the crystals of lysozyme and glucose isomerase as model samples. During sample preparation, the crystallization solution from crystal suspension was removed as much as possible, and mechanical mixing was performed with shortenings A or B using dual-syringe setups. The proportion occupied by crystals was less than 20% of the total sample volume. In these experiments, the syringe containing the crystals embedded in shortening was installed on the syringe pump in the horizontal direction to avoid beamline interference. The crystal samples were extruded from the syringe needle with a 168 μ m ID at a flow rate of 200-300 nl/min using the syringe pump. In an offline injection study, the shortening injection stream was stably extruded from the syringe at room temperature, but the extruded injection stream of shortening in the experimental hutch at 25 °C was less viscous like the unsolidified form, making it the injection stream unstable. It is believed that the shortening was partially melted by heat from the beamline device or the camera light. To solve this problem, the internal temperature of the experimental hutch was kept at 20 °C, which provided a very stable shortening injection stream. For shortening A, totals of 64000 and 48000 images were collected for glucose isomerase and lysozyme, respectively. There were 13651 and 15643 final indexed images of glucose isomerase and lysozyme, respectively ( Supplementary Figures S1 and S2 ). Glucose isomerase delivered in shortening A was processed up to 1.9 Å, and the overall SNR, CC, and R split were 4.09, 0.9576, and 19.11, respectively. Lysozyme delivered in shortening A was processed up to 1.8 Å, and the overall SNR, CC, and R split were 100, 7.87, 0.9937, and Supplementary Figures S3 and S4 ). Glucose isomerase delivered in shortening B was processed up to 1.9 Å, and the overall SNR, CC, and R split were 4.10, 0.9669, and 17.88, respectively. Lysozyme delivered in shortening B was processed up to 1.5 Å, and the overall SNR, CC, and R split were 9.27, 0.9936, and 6.58, respectively. The R work /R free values of glucose isomerase and lysozyme derived in shortening B were 17.56/20.10 and 18.49/20.69, respectively.
The glucose isomerase delivered in shortenings A and B showed clear electron density maps for amino acids from Tyr3 to Arg387 (Figure 4a ). The active site of glucose isomerase contains two metal binding sites for substrate binding and catalytic function. 29, 30 These metal binding sites of glucose isomerase are well-defined in the electron density map, and there was no negative fo-fc electron density map counted at 3 σ , indicating there was no significant radiation damage (Supplementary Figure S5) . The glucose isomerase structures delivered in shortenings A and B had high similarity with previously reported glucose isomerase structures delivered using grease (PDB code 4W4Q) 31 and nylon mesh-based fixed target scanning (6IRK) 12 with a root mean squared deviation of 0.1594-0.2549 for Cα atoms (Supplementary Figure S6) .
The lysozyme delivered in shortenings A and B showed clear electron density maps for amino acids from Lys19 to Leu147 (Figure 4b ). In lysozyme delivered in shortening A, four disulfide bonds (Csy24-Csy145, Csy48-Csy133, Cys82-Cys98, and Csy94-Csy112) were well-defined, and there was no negative fo-fc electron density map counted at 3 σ , indicating that there was no significant radiation damage (Supplementary Figure S7a) . In contrast, in shortening B, lysozyme delivered three disulfide bonds (Csy24-Csy145, Csy48-Csy133, and Cys82-Cys98) with a partial negative fo-fc electron density map counted at 3 σ (Supplementary Figure S7b) . Because the procedure and experimental setup of the SMX experiments using shortening A and B were almost identical, the partial negative fo-fc map of disulfide of lysozyme delivered in shortening B is presumed to be influenced by the delivery material rather than radiation damage caused by the X-rays. On the other hand, the overall lysozyme structures determined using both shortening A and B are similar to previously reported lysozyme structures as delivered by liquid jet sample injector (PDB code 4ET8) 31 , droplet injector (5DM9) 32 and polyacrylamide (6IG6) with a root mean squared deviation of 0.0640-0.1496 for whole Cα atoms (Supplementary Figure S8) .
Conclusion
Here, I reported the characterization and preparation of shortening as a sample delivery medium for SX experiments. SMX was successfully demonstrated using two shortening delivery media. However, shortening may require a screening procedure before in can be used, as it may exhibit differences in melting temperature, background scattering, and reduction of disulfide bonds depending on its production process and composition. In addition, because shortening is mostly fat, lipid-related protein samples may be unstable due to specific or non-specific interactions between crystals and shortening. Nevertheless, the advantages of shortening are clear in that it is easy to store and much less expensive than previously reported sample delivery media (e.g., the price is 45,000,000 times lower than that of LCP). Moreover, the transferal of shortening is straightforward by the temperature control of the solid-liquid phase. Therefore, shortening is a promising delivery material for SX experiments with existing hydrophobic delivery materials.
Materials and Methods
Crystallization
Glucose isomerase from Streptomyces rubiginosus and lysozyme from chicken egg whites were purchased from Hampton Research (HR7-098) and Sigma-Aldrich (L6876), respectively. Glucose isomerase was supplied as a crystal suspension, and it was used directly for SMX experiments, as previously reported. 12 The lysozyme was crystallized using a previously reported procedure. 12 The crystal sizes of glucose isomerase and lysozyme were [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] μ m and <60 μ m, respectively.
Characterization of shortening
Shortening A was purchased from Samyang (Republic of Korea) and shortening B from Ottogi (Republic of Korea). Shortening A was composed of palm oil and beef tallow.
Shortening B was composed of palm olein oil, palm stearin oil, palm hydrogenated oil, tallow, and d-Tocopherol. The melting temperatures of shortenings A and B were measured on a water bath and judged visually. The solid phase shortening at room temperature was initially transferred to a glass vial using a spatula. During the transfer of the shortening to the syringe, the shortening in the glass vial was immersed in hot water (~100 °C) in a beaker for 10-20 s.
Liquid shortening was transferred into a 100 μ l syringe (Hamilton, 81065-1710RNR) using a pipette, and was then left to stand until solid. A syringe needle of 168 ID was connected to the syringe containing the shortening, and the syringe was vertically installed in a Fusion Touch 100 syringe pump (CHEMYX). The syringe plunger was pushed by a mechanical force from the syringe pump 33 and extruded the sample at a flow rate of <200 nl/min. The shortening containing crystals was delivered by a syringe pump-based sample delivery system 33 through a syringe needle of 168 μ m ID at a flow rate of 200-300 nl/min. Crystals were X-ray exposed for 100 ms. Diffraction images were recorded on a Pilatus 6M with 10 Hz readout.
Crystal embedding in shortening
Data processing and structure determination
The hit images with diffraction pattern were filtered using the Cheetah program with the peakfinder8 algorithm. 34 The hit images were indexed and merged using the CrystFEL program. 35 The phase problem of the lysozyme and glucose isomerase was solved by molecule replacement using the Phaser-MR in PHENIX 36 , with the crystal structures of lysozyme (PDB code 6IG6) 21 and glucose isomerase (PDB code 5ZYD) 30 used as the search models. The model building and refinement were conducted using Coot 37 and Phenix.refinement in PHENIX, respectively. 36 The geometry was analysed using MolProbity. 38 Figures were generated using PyMOL (https://pymol.org/).
Background scattering analysis
Shortening A, shortening B, and LCP delivery media were passed through a syringe needle with a 168 μ m ID. Each delivery medium was exposed to X-rays of 1.3 x 10 12 photons/flux for 100 ms. The background scattering from 1.6 Å to the beam centre was analysed using the average intensity for 100 images. The background intensities of the delivery media were analysed using ADXV (https://www.scripps.edu/tainer/arvai/adxv.html). 
Σ ||F obs |-|F calc ||/Σ|F obs |, where F obs and F calc are the observed and calculated structure-factor amplitudes respectively. R free was calculated as R work using a randomly selected subset (10%) of unique reflections not used for structure refinement. 
